期刊文献+

乳腺癌周微淋巴管密度与腋淋巴结转移的相关性研究 被引量:8

Study between axillary lymph node metastasis and density of lymphatic microvessel in the tissue adjacent primary breast carcinoma
下载PDF
导出
摘要 目的探讨乳腺癌癌周组织中微淋巴管的密度与腋窝淋巴结转移之间的相关性。方法应用免疫组化的方法,采用Ⅷ因子、Ⅳ型胶原及VEGFR-3单抗将67例Ⅱ期乳腺癌癌周组织中微淋巴管和微血管加以区别。并用装有10X10网格的目镜,在200倍光镜下对染色阳性的微内皮管计数。结果在36例腋窝淋巴结转移组中,乳腺癌周组织的微淋巴管密度是(6.33±0.37)/HPF(×200),在31例非转移组中,癌周组织的微淋巴管密度是(2.81±0.30)/HPF(×200),(P<0.001);转移组的微血管密度是(19.75±0.47)/HPF(×200),非转移组微血管密度是(25.65±0.81)/HPF(×200),(P<0.001);相关性分析显示:癌周组织Ⅷ因子染色微管密度与腋窝淋巴结转移无相关性(r=-0.040,P>0.05),Ⅳ型胶原染色的微血管密度与腋窝淋巴结转移之间成负相关(r=-0.844,P<0.001),VEGFR-3染色的微淋巴管密度与腋窝淋巴结转移成正相关(r=0.841,P<0.001)。结论乳腺癌腋淋巴结转移状态不同,其癌周组织中微淋巴管密度差异有显著性;乳腺癌癌周微淋巴管密度越高,腋窝淋巴结转移的可能性越大。 [Objective] To analyse the interrelation between axillary lymph node metastasis and the density of lymphatic microvessel in the tissue adjacent primary breast carcinoma. [Methods] Immunohistoehemisty was employed to differentiate lymphatic microvessel from blood microvessel in 67 samples from patients with primary breast carcinoma (stage T2) by means of mono-antibodies of factor Ⅷ, typeⅣcollagen and VEGFC-R. [Results] The densities of lymphatic microvessel in the tissue adjacent primary breast carcinoma in lymph node metastasis group (LNM group, 36 cases) and non-lymph node metastasis group (NLNM group, 31 cases) were (6.33±0.37)/HPF (×200) and (2.81±0.31)/HPF (×200) respectively (P 〈0.001); and that the densities of blood microvessel in the tissue adjacent primary breast carcinoma in LNM group and NLNM group were (19.75±0.47)/HPF (×200) and (25.65±0.81)/HPF (× 200) respectively (P 〈0.001). The result of interrelation analysis showed that there was not any relationship between the density of microvessel positively stained by factor Ⅷ in the tissue adjacent primary breast carcinoma and the rate of axillary lymph node metastasis (r =-0.040, P 〉0.05); there appeared a negative relationship between the density of blood microvessel positively stained by type lV collagen in the tissue adjacent primary breast carcinoma and the rate of axiUary lymph node metastasis (r =-0.844, P 〈0.001); and there was an positive relationship between the density of lymphatic microvessel positively stained by VEGF-C in the tissue adjacent primary breast carcinoma and the rate of axillary lymph node metastasis (r =0.841, P 〈0.001). [Conlusion] According to the different status of axillary lymph node, the density of lymphatic microvessel in the tissue adjacent primary breast carcinoma exists obvious difference. The higher the density of lymphatic microvessel in the tissue adjacent primary breast carcinoma is, the more possibly the axillary lymph node metastasis occurs.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第5期551-553,557,共4页 China Journal of Modern Medicine
基金 西安市科技攻关项目(SF200228)
关键词 乳腺癌 微淋巴管密度 转移 breast carcinoma lymphatic microvessel metastasis
  • 相关文献

参考文献8

  • 1FIDLER IJ.Molcular biology of cancer:invasion and metastasis.In:DevitaVT.Hellman S.Rosenberg SA.eds.Cancer.Principles and Practice of Oncology[M].5th ed.Philadelphia,Pa:Lippincott-Raven Publishers,1997:135-152.
  • 2GASPARINI G,HARRIS AL.Clinical importance of the determination of tumor angiogenesis in breast carcinoma:much more than a new prognostic tool[J].J Clin Onncol,1995,13:765-782.
  • 3康华峰,王西京,刘小旭,代志军,薛锋杰,薛兴欢.蓝染料法乳腺癌前哨淋巴结活检的应用价值(英文)[J].中国现代医学杂志,2005,15(20):3054-3056. 被引量:9
  • 4JETTSCH M,KAIPAINEN A,JOUKOV V,et al.Hyperplasia of lymphatic vessels in VEGF-C transgenic mice[J].Science,1997,276:1423-1425.
  • 5NATHANSON S D,ZARBO R J,WECHNA D L,et al.Microvessels that predict axillary lymph node metastases in patients with breast cancer[J].Arch Surg,2000,135:580-594.
  • 6LEE J,GRAY A,YUAN J,et al.Vascular endothelial growth factor-related protein:a ligand and specific activator of the tyrodine kinase receptor FLT-4[J].Proc Nati Acad Sci USA,1996,93:1988-1992.
  • 7YULONG HE,TERHI KARPANEN,KARI ALITALO.Role of lymphangiogenic factors in tumor metastasis[J].Biochimica et Biophysica Acta,2004,1654:3-12.
  • 8VALTOLA R,SALVEN P,HEIKKILA P,et al.VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer[J].Am J Pathol,1999,154:1381-1390.

二级参考文献8

  • 1SANIDAS EE, BREE E, TSIFTSIS DD. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer?[J].Am J Surg, 2003, 185: 202-210.
  • 2KRAG D, WEAVER D, ASHIKGA T, et al. The sentinel node in breast cancer: a multicenter validation study [J]. N Engl J Med,1998, 339: 941-946.
  • 3YILMAZ E, LEBE B, BALCI P, et al. Comparison of mammographic and sonogramphic findings in typical and atypical medullary carcinomas of breast[J]. Clin Radiol, 2002, 57: 640-645.
  • 4HOLMES CE, MUSS HB. Diagnosis and treatment of breast cancer in the elderly[J]. CA Cancer J Clin, 2003, 53: 227-244.
  • 5KERN KA. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid[J]. J Am Coll Surg, 2002, 195:467-475.
  • 6GRAY R J, POKAJ BA. A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping[J].Am J Surg, 2004, 188: 423-425.
  • 7TUTTLE TM, COLERT M, CHRISTENSEN R, et al. Subareolar injection of 99m-Tc facilitates sentinel lymph node identification [J].Ann Surg Oncol, 2002, 9: 77-81.
  • 8GIULIANO AE, KIRGAN DM, GUENTHER JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 1994, 220: 391-401.

共引文献8

同被引文献70

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部